Portfolio Analysis and Planning for Pharma and Biotechs

Portfolio Analysis and Planning for Pharma and Biotechs

Consulting services that strengthen your pipeline by evaluating gaps, opportunities, and redundancies in your portfolio.
Get In Touch
Portfolio Analysis and Planning for Pharma and Biotechs

Overview

We help you understand how market dynamics, clinical innovations, and competitive threats affect your products' future potential, so you can prioritize your pipeline and align your portfolio with your business strategy.

What do you get with Portfolio Analysis and Planning for Pharma and Biotechs?

Deep knowledge of market characteristics and dynamics

  • Assess pipeline composition and gap
  • analysis Appraise the landscape, competitive market, and market access 
  • Evaluate product clinical utility and commercial value opportunity -
  • Forecast revenues and asset valuation

We support our engagements with accurate and reliable data from a range of sources, including our own CancerMPact®, Epi Database®, and Cerner Real-World Data™

We use a holistic approach, integrating the appropriate experts and data to meet your requirements.

More than 25 years of experience in oncology

Our teams are comprised of over 100 oncology specialists, many with advanced degrees and commercial pharma experience. Their collective experience brings a holistic perspective to your engagement and is built on collaboration, expertise, and efficiency.

Client Results

Anticipate and manage challenges around your target market.

Gain a deep knowledge of market characteristics and dynamics.

Make confident decisions with guidance from our clinical, epidemiology, access, and forecasting experts.

Leverage robust and comprehensive data sources.